3 æäžæ¬ãåä¿¡ãã¬ã€ãå
ã£ããä»¶å㯠ãAAIC 2026 â Abstract Decisionã ãå©ççžåé瀺ããã©ãããã©ãŒã ãªã³ã¯ãå§å¡äŒããã®è¬èŸãã¹ã¯ããŒã«ã§èªã¿é£ã°ããšãããã«ããããã£ã â ããªãã®èªç¥çç ç©¶ã¯æ¡æãããããã³ãã³éå¬ãŸã§å®å 8 é±éã®æçšãªæºåæéããã㊠2,500 æåã®æé²ããExCeL ã§ 4,000 æ¬ã®ãã¹ã¿ãŒãšç«¶ãåãã·ãŒãã«ä»äžããªããã°ãªããªããããŠãã©ãããæãä»ããã¹ããã
æ¬çš¿ã¯ãAAIC 2026 ã®æ¡æéç¥ãåãåã£ãåºç€ç ç©¶è
ãç¥çµå
ç§å»ãèšåºè©Šéšè²¬ä»»è
åãã®å®è·µçã¬ã€ãã§ãã圢åŒèŠå®ã6 åºåã®çºè¡šãã©ãã¯ãæºåãŠã£ã³ããŠããããŠæ¬åŠäŒã«åºæã®ç¹åŸŽãšã㊠â ä»ã®äž»èŠç¥çµåŠäŒã«ã¯ååšããªã Beyond the Data èŠèŠèžè¡æçš¿æ ãæ±ããŸãã
AAIC 2026 ExCeL London ãã¹ã¿ãŒã»ãã·ã§ã³äŒå ŽïŒ4,000 æä»¥äžã®èªç¥çç ç©¶ãã¹ã¿ãŒãAlzheimer ç
ã¡ã«ããºã å³ãè°è«ããç ç©¶è
ïŒå³ã¯ SciFig ã§çæïŒ
éææ§ã«é¢ããæ³šèšïŒæ¬èšäºã®å³ã¯ SciFig AI ã§çæãããç§åŠçæ£ç¢ºæ§ã«ã€ããŠèè
ã確èªããŠããŸããåŒçšããå»åŠçèšè¿°ã¯ãã¹ãŠæ»èªæžã¿ã®æ
å ±æºããã³ AAIC å
¬åŒè³æã«ãªã³ã¯ããŠããŸãã
1. AAIC 2026 ã®å
šäœåïŒæ¥çšãäŒå Žã6 åºåã®æ¡æãã©ãã¯
Alzheimer's Association International Conference 2026 ã¯ãšãŒããããžæ»ãã
ExCeL London ã§éå¬ãããŸããäž»å¬ã¯
Alzheimer's Association ïŒ2026-05-22 ã¢ã¯ã»ã¹ïŒããã¬ã«ã³ãã¡ã¬ã³ã¹ã¯
7 æ 10ã11 æ¥ ãã¡ã€ã³ããã°ã©ã ã¯
7 æ 12ã15 æ¥ ãAAIC For All ã¯
7 æ 16 æ¥ ã«è¡ãããŸããæ¬äŒè°ã«ã¯çŽ 8,000ã10,000 åã®èªç¥çç ç©¶è
ãèšåºå»ãç ä¿®å»ãéãŸããåºç€ç¥çµç§åŠããã€ãªããŒã«ãŒãèšåºè©Šéšãç¥çµç»åãç¥çµå¿çåŠãã±ã¢ç ç©¶ã«ãããè€æ°ãã©ãã¯ãçšæãããŸãïŒ
AAIC 2026 Home (Accessed 2026-05-22)ã2026-05-22 ã¢ã¯ã»ã¹ïŒã
æ¡æããããã¹ãŠã®æé²ã¯ Alzheimer's & Dementia® (Accessed 2026-05-22) ïŒ2026-05-22 ã¢ã¯ã»ã¹ïŒã®ãªãŒãã³ã¢ã¯ã»ã¹ãµããªã¡ã³ããšããŠå
¬éãããŸã â ãµããªã¡ã³ããå
¬éãããç¬éããããªãã®ç ç©¶ã¯åŒçšå¯èœã«ãªããŸããScientific Programme Committee ã¯æçš¿ã 6 åºåïŒç¬¬ 5 ç¯ïŒã«æ¯ãåããããããæ¡æã㯠800 åã®åå è
ãåã«ãã 12 åã®ç»å£çºè¡šãæå³ããããšããéããªãã¹ã¿ãŒæ ãæå³ããããšãããŸã㯠â èŠèŠèžè¡æçš¿ã®å Žåã«ã¯ â ãã¥ã¬ãŒã·ã§ã³ãããå±ç€ºã®äžã«æ²ç€ºãããäœåãæå³ããããšããããŸãã
2. 2026 幎倧äŒã®å®å
šæçš¿ã¿ã€ã ã©ã€ã³
éå»ãšãªã£ãç¯ç®ãšããããã蚪ããç¯ç®ã以äžã«ãŸãšããŸãã
æ¥ä» ãã€ã«ã¹ããŒã³ 2026 幎 1 æäžæ¬ éåžžæé²æçš¿éå§ 2026 幎 2 æäžæ¬ éåžžæé²æçš¿ç· å 2026 幎 3 æäžæ¬ éåžžæé²ã®æ¡æéç¥éä¿¡ â çŸåšå° 2026 幎 5 æäžæ¬ Developing TopicsïŒlate-breakingïŒæé²æçš¿ç· å 2026 幎 5 æ 15 æ¥ ã¢ãŒãªãŒããŒãç»é²ç· å 2026 幎 6 æäžæ¬ Developing Topics æ¡æéç¥éä¿¡ 2026 幎 7 æ 10ã11 æ¥ AAIC ãã¬ã«ã³ãã¡ã¬ã³ã¹ïŒISTAARTãå°éé åå¥ããŒãã£ã³ã°ïŒ 2026 幎 7 æ 12ã15 æ¥ AAIC2026 ã¡ã€ã³ããã°ã©ã ãExCeL London 2026 幎 7 æ 16 æ¥ AAIC For AllïŒäžè¬å
¬éæ¥ïŒ
éåžžæ¡æãåãåã£ãèè
ã¯ã3 æäžæ¬ããéå¹ãŸã§ããã 14ã15 é±éãããŸã â äœè£ãããããã«é¿ããŸãããæ¬æ¥ã®è²¬åãIRB ç
§äŒãå
±èè
ã¬ãã¥ãŒãµã€ã¯ã«ãå°å·æ¥è
ãå¿
èŠãšãã 4ã6 å¶æ¥æ¥ãå·®ãåŒããšãããã§ããããŸããã
6 æäžæ¬ã«éç¥ãåãã Developing Topics èè
ã¯å®å 4 é±éã«è¿ã ãããèŠèŠã¯ãŒã¯ãããŒãããã«å¿ããŠå§çž®ããå¿
èŠããããŸããå
·äœçãªç· åã¯
å
¬åŒ AAIC æé²æŠèŠ (Accessed 2026-05-22)ïŒ2026-05-22 ã¢ã¯ã»ã¹ïŒã§ç¢ºèªããŠãã ãã â Alzheimer's Association ã¯äŒææ¥è¿æã«æ¥ä»ã 1 é±éã»ã©åããããšããããŸãã
3. æçš¿ããæé²ã¿ã€ãïŒOriginalãUpdateãEncore
æçš¿èŠå®ã¯ãã§ã«éãå»ããŸããããããã¯æ»èªè
ããã£ã仿¿èªããææžã®åœ¢ã決å®ã¥ããŠããŸããAAIC 㯠3 ã€ã®æçš¿ã¿ã€ããåãä»ããéžæããã¿ã€ãã«ãã£ãŠãã¹ã¿ãŒæ»èªè
ã«æç€ºãã¹ãæ°èŠããŒã¿ã®éãæ±ºãŸããŸãã
Original æé²ã¯æªçºè¡šããŒã¿ãæç€ºãããã®ã§ããUpdate æé²ã¯éå»ã« AAIC ãžæçš¿ããç ç©¶ãæ°èŠè§£æãé·æè¿œè·¡ã§æ¡åŒµãããã® â æ»èªè
ã¯æç¢ºãªå·®åãæåŸ
ããŸããEncore æé²ã¯ AAIC ç¹æã®æ çµã¿ã§ãïŒçŽè¿ 12 ã¶æä»¥å
ã«ä»ã®åœéäŒè°ã§æ¢ã«çºè¡šãããç ç©¶ããã®ãŸãŸæçš¿ã§ããŸãããããã°ã©ã ã«ã¯æ²èŒããããã®ã® Alzheimer's & Dementia® ãµããªã¡ã³ããžã®åæ²èŒã¯ è¡ãããŸãã ããã®ç¹ã¯åŒçšæŠç¥äžéèŠã§ã â Encore ã®ç ç©¶ãæ¢ã«äž»èŠãžã£ãŒãã«ã«æ²èŒæžã¿ã®å ŽåãAAIC ããã°ã©ã æ²èŒã¯ãªãŒããåºããŸããæ°ããªåŒçšå¯èœãªãã¡ã¬ã³ã¹ã¯è¿œå ãããŸãããã©ã®ã¿ã€ããæçš¿ãããã«é¢ãããããã¹ã¿ãŒæ»èªè
ã¯ããªãã®æé²æ¬æã«ã¢ã¯ã»ã¹ã§ãããããå³ã宣èšããã³ããŒãèŠæš¡ããšã³ããã€ã³ããšççŸããŠããã°æ°ã¥ããŸãã
4. AAIC 2026 æºåïŒæ¡æããã® 8 é±éãŠã£ã³ããŠ
15 é±éã®ã«ã¬ã³ããŒã¯äœè£ãããããã«é¿ããŸããæ¬æ¥ã®è²¬åãIRB ç
§äŒãå
±èè
ãµã€ã¯ã«ãå€å£äŒæãå°å·æ¥è
ãå¿
èŠãšãã 4ã6 å¶æ¥æ¥ãå·®ãåŒããšãæçšãªãŠã£ã³ããŠã¯ å®å 8 é±é ã«è¿ããªããŸããDeveloping Topics èè
ã¯ãã®ååã®äžã§åãããšã«ãªããŸãã
çŸå®çãªã¹ã±ãžã¥ãŒã«ã¯æ¬¡ã®éãã§ãã
第 1ã2 é± â ãã©ãã¯æŠç¥ã決ãããæé²ã® 5 ã»ã¯ã·ã§ã³ã 4ã5 æã®ãã¹ã¿ãŒããã«ã«ãããã³ã°ããããœãããŠã§ã¢ãéãåã«ãçŽã®äžã§äž»åœ¹å³ â ã¢ããã€ãæãTREM2 ã·ã°ãã«äŒéãæµ·éЬèçž® â ã®ã¹ã±ãããæãã
第 3ã4 é± â èŠèŠã¢ã»ãããçæãããAdobe Illustrator ãªã 1 é±éãããçµè·¯å³ããããã³ãã調æŽãšãã¯ã¿ãŒæŽç·Žã«éäžãã 1 æ¥ã«å§çž®ãããŸãã
第 5ã6 é± â ã¬ã€ã¢ãŠããã¿ã€ãã°ã©ãã£ããã¢ã¬ãã¥ãŒãããŒã å€ã®ç¥çµç
çåŠè
1 åãšçµ±èšå®¶ 1 åã«ãã©ãããéãã圌ãã¯ããªããäœåºŠãèŠãããŠæ°ã¥ããªããªã£ãã©ãã«ãªãã® Braak ã¹ããŒãžãææ§ãª p å€ãæŸã£ãŠãããã
第 7ã8 é± â å°å·æ ¡æ£ãçºéããã³ãã³æ ç¹ã®å°å·æ¥è
ãæ©ãã«äºçŽãã â 7 æã¯èгå
ãã€ã·ãŒãºã³ã§å°å·åŸ
ã¡è¡åã䌞ã³ãã
Developing Topics èè
ã¯å段éããããååã«å§çž®ããããšã«ãªããã€ãŸãèŠèŠçæã¯çœçŽãã£ã³ãã¹ããéå§ã§ããŸããã第 8 ç¯ã®ãæé² PDF æå
¥ / ã¹ã¿ãŒã¿ãŒå³åºåãã¯ãŒã¯ãããŒã¯ããã®ã¿ã€ã ã©ã€ã³ã§ã¯å®è³ªçã«å¿
é ã§ãã
5. AAIC 2026 ã«ããã 6 ã€ã®çºè¡šåœ¢åŒ
æ¬å¹ŽåºŠã®äŒè°ã¯ãæ¡æãããæé²ã 6 åºåã®ããããã«å²ãåœãŠãŸããåºåã®å®çŸ©ã¯
å
¬åŒ AAIC æé²ããã³ã»ãã·ã§ã³ã¬ã€ãã©ã€ã³ (Accessed 2026-05-22)ïŒ2026-05-22 ã¢ã¯ã»ã¹ïŒã«ãããŸããèªåãã©ã®åºåã«å
¥ã£ãããææ¡ããããšã§ããã®åŸã®ããããèŠèŠçå€æãæ±ºãŸããŸãã
AAIC 2026 6 段éçºè¡šéå±€ïŒPodium PresentationãFeatured Research SessionãPerspectives SessionãClinical Toolbox SessionãPoster PresentationãBeyond the Data èŠèŠèžè¡ãã©ãã¯ãèŽè¡èп𡿳šéä»ãïŒå³ã¯ SciFig ã§çæïŒ
Podium Presentation â æäžäœåºåãæšæºçã«ã¯ 12 åã®çºè¡šã« 3 åã®ã¢ãã¬ãŒãèšè°ãã¹ã©ã€ããè«èšŒãæ
ãããµããŒããã¹ã¿ãŒãããã°ããã¯ç»å£åŸã®ããªãã£ã¹ã¢ã¯ãŒãã·ãŒããšããŠæ©èœããŸãã
Featured Research Session (FRS) â 2 åã®åº§é·ãš 4ã6 åã®çºè¡šè
ã§æ§æããã 90 åã®ããŒããããã¯ããæã¢ããã€ãæäœïŒæå¹æ§ãš ARIA å®å
šæ§ãã®ãããªå³å¯ã«ã¹ã³ãŒãããããããã¯ãæ±ããŸããæ ŒãšããŠã¯ãžã£ãŒãã«ç¹éå·ã«çžåœããŸã â æŽç·Žããã 8ã10 åã®ã¹ã©ã€ããšãå
ç¢ãªãã¹ã¿ãŒã®äž¡æ¹ãå¿
èŠã§ãã
Perspectives Session â åãã 90 åãã¬ãã¥ãŒè«æã©ãŠã³ãããŒãã«åœ¢åŒãçºè¡šè
ã¯å ±åã§ã¯ãªãçµ±åãè¡ããŸãã
Clinical Toolbox Session â å®å°ã®ç¥çµå
ç§å»ãè幎å»åŠå»ãããŒã¹ãã©ã¯ãã£ã·ã§ããŒåãã®èšåºæè²ãã©ãã¯ãèŠèŠè³æã¯ã¡ã«ããºã å³ããããæææ±ºå®ããªãŒã蚺æãããŒãã£ãŒãã«å¯ããŸãã
Poster Presentation â å€å
žçãªåœ¢åŒã§ãæ¡ææé²ã®å€§å€æ°ãå²ãæ¯ãããå
ã§ããèŠèŠçæçæ§ã®ããŒãã«ãããã§æãé«ããªããŸã â åãããŒã«ã®æ°åæãšæ³šç®ã奪ãåããŸãã
Beyond the Data â AAIC ç¬èªã®èŠèŠèžè¡ãã©ãã¯ãç¬ç«ããŠå¯©æ»ããã第 7 ç¯ã§è©³è¿°ããŸããéåžžæçš¿ãšäžŠè¡ããæ¡æã§ãããæä»çã§ã¯ãããŸããã
èŠèŠæŠç¥ã¯åºåã«ãã£ãŠåå²ããŸããPodium ãš FRS ã®çºè¡šè
㯠8ã12 åã®ãŠã©ãŒã¯ã¹ã«ãŒäžã«èªãããã©ãã£ããªå³ãå¿
èŠã§ããPoster Presentation ã®èè
㯠90 ç§ã®ãã£ãšèŠã«ãèããèªç«ããæ
å ±å¯åºŠãå¿
èŠã§ãã
6. ãã¹ã¿ãŒã¯ã©ãèŠããã¹ããïŒèªç¥çç ç©¶ã®èŠèŠçã¢ããããŒ
AAIC ã®ãã¹ã¿ãŒããŒã«ãæ©ãã°ãã»ãŒãã¹ãŠã®æ¡ææé²ã«åãèŠèŠèªåœãç¹°ãè¿ãããããšã«æ°ã¥ããŸã â ãããã¯æ¬åéãäºãã«ã³ãã¥ãã±ãŒã·ã§ã³ãåãéã®æ§é çè骚ã§ãã
ã¢ããã€ãããŒã¿æã®ç
ç
åºç€ç§åŠãšåµè¬éçºã®äž¡æ¹ã§æãåçŸãããå³ã§ããç·»å¯ã³ã¢æãã³ãŸãæ§æãåšå²ã®ãžã¹ãããã£ãã¯ç¥çµçªèµ·ãã³ããã貪é£ããæŽ»æ§åãã¯ãã°ãªã¢ãè¿åã®åå¿æ§ã¢ã¹ãããµã€ããç ç©¶ãäœããã®åœ¢ã§ Aβ ã«è§Šããå ŽåãèŽè¡ã¯ãããæ¹åä»ãããã«ãšããŠæåŸ
ããŸãã
Alzheimer ç
è³ã®ã¢ããã€ãããŒã¿æç
çïŒç·»å¯ã³ã¢æããžã¹ãããã£ãã¯ç¥çµçªèµ·ã掻æ§åãã¯ãã°ãªã¢ãAβ42 ç·ç¶ã³ã¢ã®æé¢æ³šéä»ãïŒå³ã¯ SciFig ã§çæïŒ
ã¢ããã€ãã»ã¿ãŠç
çå³ã®ããæ·±ãææ³ã«ã€ããŠã¯ã
AAIC 2026 ãã¹ã¿ãŒåãã¢ããã€ãã»ã¿ãŠã¡ã«ããºã å³è§£ ãåç
§ããŠãã ããã
APP ããã»ãã·ã³ã°ãã»ã¯ã¬ã¿ãŒãŒãè§£ååŠ
ç ç©¶ãåµè¬éçºããã€ãªããŒã«ãŒæ€èšŒãå®¶ææ§ AD å€ç°ã®ããããã«é¢ããå Žåãα/β/γ-ã»ã¯ã¬ã¿ãŒãŒããã»ãã·ã³ã°ã®æš¡åŒå³ãååè«çãæ¯ããŸã â APP ã® sAPPαãsAPPβãC99ãAICDãAβ40/42 ãžã®åæã¯ç¥çµç§åŠã§æãæãããå³ã® 1 ã€ã§ãããšåæã«ãæã誀ã©ãã«ãããããå³ã® 1 ã€ã§ããèšåºããã³ç¥çµå¿çåŠã®ãã¹ã¿ãŒã«ã¯è§£ååŠçæ¹åä»ãããã«ãå ãããŸãïŒæµ·éŠ¬ã® CA1 / CA3 / æ¯ç¶åãNFT äŒæã®èµ·ç¹ãšãªãå
å
ç®è³ª II å±€ãç¢ç¶æè³ã®ããã©ã«ãã¢ãŒããããã¯ãŒã¯ããŒããªã©ã
ãã¯ãã°ãªã¢ãTREM2ãç¥çµçç
ç¥çµççããŒãã¯ããããªãµããããã¯ããæ¬äŒè°æå€§çŽã®ãã©ãã¯ã® 1 ã€ãžãšæé·ããŸãããéæ¢ç¶æ
vs 掻æ§åãã¯ãã°ãªã¢ãTREM2-DAP12-SYK ã·ã°ãã«äŒéãdisease-associated microgliaïŒDAMïŒç¶æ
é·ç§»ããã¯ãã°ãªã¢ã»ã¢ã¹ãããµã€ãéã®ã¯ãã¹ããŒã¯ â ãã®ããŒãã§ TREM2 æš¡åŒå³ã®ãªããã¹ã¿ãŒã¯ãä»ãäžå®å
šã«èŠããŠããŸããŸãã詳现ã¯
AAIC 2026 åã TREM2 ãã¯ãã°ãªã¢ç¥çµççå³è§£ ã§æãäžããŸãã
æ Aβ æäœã¡ã«ããºã
2024ã2026 幎ã®åµè¬ãµã€ã¯ã«ã¯ãlecanemabãdonanemabããããŠæ¬¡äžä»£ã®æã¢ããã€ãæäœãèšåºè°è«ã®äžå¿ã«æ®ããŸããããããã®ã¡ã«ããºã â ããããã£ããªã«ãžã® Fc ä»åšãã¯ãã°ãªã¢è²ªé£ vs N3pE ããã°ã«ã¿ãã³é
žä¿®é£Ÿæã³ã¢ â ã¯è¿å¹Žã® AAIC ã§æã質åãããèŠèŠè³æã§ãã
Lecanemab ããã³ donanemab æã¢ããã€ãæäœã¡ã«ããºã ïŒAβ ããããã£ããªã« vs N3pE æã³ã¢ãžã®çµåãFc ä»åšãã¯ãã°ãªã¢è²ªé£ã18 ã¶ææ²»çã§ã®æã¯ãªã¢ã©ã³ã¹ïŒå³ã¯ SciFig ã§çæïŒ
詊éšã¹ããŒããš SciFig ãæ±ããªãããš
ãã¹ãŠã®èšåºæé²ã¯è©Šéšãã¶ã€ã³å³ããå§ãŸããŸã â ä»å
¥è©Šéšã«ã¯ CONSORT ãããŒã芳å¯ã³ããŒãã«ã¯æ°Žå¹³ã¿ã€ã ã©ã€ã³ããããã®å³ãã¹ããŒã¹ãç²åŸããã®ã¯ãèªè
ãæ¹æ³ããã¯ã¹ã«èžã¿èŸŒãåã« ãå®éã«äœãããã®ãïŒã ã«çããããã§ãã
èªç¥çã®å³ã®ãã¡ã2 ã€ã®ã«ããŽãªã¯ text-to-figure ããŒã«ããåºå ããã ãæ¢åã®ãã€ãã©ã€ã³ã«çãŸããŸãã
PET / MRI ã¹ãã£ã³ ïŒã¢ããã€ã PETãã¿ãŠ PETãæ§é MRIãfMRI 掻æ§åãããïŒâ ãããã¯ç»åæœèšããåºãŠããŸããSciFig ã¯æžãåºãããã¹ãã£ã³ã«æ³šéãä»ãããã¹ã¿ã€ã«ãæŽãããã¯ã§ããŸãããåç»åãã®ãã®ãåæããããšã¯ãããŸããã
Kaplan-Meier æ²ç·ããã©ã¬ã¹ãããããããã®ä»çµ±èšå³ â ããã㯠GraphPad Prismãsurvminer ãåãã RããŸã㯠SPSS ãããçç©çµ±èšå®¶ãèšå®ããåºçæ°Žæºã®ããã©ã«ãã§åºåãããŸãã
ã©ã®å³ãã©ã®ããŒã«ããåºãŠãããã«ã€ããŠæ£çŽã§ãã£ãŠãã ãããæ»èªè
ã¯ã¹ã¿ã€ã«çãªäžæŽåã«æ°ã¥ããŸã â ããããã®å³ãæ£ç¢ºæ§ã®ãã¡ã€ã³å
ã«çããAI ãå®éã«ã¯åæããŠããªãããŒã¿ãåæãããšç€ºåããããšã¯é¿ããŸãããã
7. Beyond the DataïŒAAIC ç¬èªã®èŠèŠèžè¡æçš¿ãã©ãã¯
Alzheimer åŠäŒã®ãã®äŒè°ã«ã¯ãä»ã®äž»èŠç¥çµåŠäŒã«ã¯ååšããªãç¹åŸŽããããŸãïŒ
Beyond the Data ã§ãã
å
¬åŒ Beyond the Data ããŒãž (Accessed 2026-05-22)ïŒ2026-05-22 ã¢ã¯ã»ã¹ïŒã«èšèŒãããŠãããåŸæ¥ã®ãã¹ã¿ãŒåœ¢åŒã«åãŸããªãèŠèŠäœåã®ããã®å¥æçš¿ãã©ãã¯ã§ãã
äœãæ¡æããããã 3 ã€ã®ã«ããŽãªïŒç ç©¶å³è¡šïŒç¥çµç»åè§£æãå
ç«çµç¹ååŠãè³ãªãŒãã©ãžãªã°ã©ãã£ãé»åé¡åŸ®é¡ïŒãç§åŠçã€ã©ã¹ãã¬ãŒã·ã§ã³ïŒã¡ã«ããºã å³ãè§£ååŠçèŠèŠåãæŠå¿µçã¢ãŒãã¯ãŒã¯ïŒããããŠåçïŒé¡åŸ®é¡ã¢ãŒããèšåºç°å¢ããã¥ã¡ã³ã¿ãªãŒãé©åãªåæååŸãšå人è奿
å ±é€å»ãçµãæ£è
ã»ä»è·è
ããŒãã¬ãŒãïŒãæçš¿ã¯ç§åŠç䟡å€ãšèŠèŠçæå·§ã®ãããåçã®éã¿ä»ãã§æ¡ç¹ãããŸã â ç§åŠåŠäŒããã°ã©ã ãšããŠã¯çããä»çµã¿ã§ãã
éžèãšè¡šåœ°ã 3 åã®ãã¡ã€ããªã¹ãã Beyond the Data Art Competition ã§è¡šåœ°ãããç¿å¹ŽåºŠã®åå ãã§ããŒã·ããã«å ããAlzheimer's & Dementia® ã®ãžã£ãŒãã«è¡šçŽæ åè£ãšããŠæ€èšãããŸããéžã°ããäœåã¯ãã¹ã¿ãŒããŒã«å
ã®ãã¥ã¬ãŒã·ã§ã³å±ç€ºãšãªã¢ã«æ²ç€ºãããŸãã
SciFig ã®äœçœ®ã¥ãã 3 ã«ããŽãªã®ãã¡ãSciFig 㯠ç§åŠçã€ã©ã¹ãã¬ãŒã·ã§ã³ ã«å
¥ããŸã â ã¡ã«ããºã å³ãçµè·¯æš¡åŒå³ãæŠå¿µçè§£ååŠã¢ãŒããIHC ãã¬ãŒããé»åé¡åŸ®é¡ãé¡åŸ®é¡ãŸãã¯èšåºåçã¯æ¬ããŒã«ã®å®åç¯å²å€ã§ããTREM2 å容äœã¯ãã¹ããŒã¯ã®æ§åŒåã€ã©ã¹ãããBraak ã¹ããŒãžãéããã¿ãŠäŒæã®èžè¡çã¬ã³ããªã³ã°ã¯ç¯å²å
ã§ããäžæ¹ãæã貪é£ãããã¯ãã°ãªã¢ã®å
±çŠç¹ç»åã¯ããªãã®é¡åŸ®é¡ã®ä»äºã§ãã
2027 幎æçš¿ãŠã£ã³ã㊠ã¯
éå»å¹ŽåºŠãèžãŸãããšãããã 11 æ ã«éå§ãããåŸåããããŸã â å
·äœçãªæ¥ä»ã¯æ«å®ãšããŠæ±ãã2026 幎ç§ãè¿ã¥ããã
AAIC Beyond the Data ããŒãž (Accessed 2026-05-22)ïŒ2026-05-22 ã¢ã¯ã»ã¹ïŒã§ç¢ºèªããŠãã ãããæ¢ã« 2027 幎ãèŠéã«å
¥ããŠãããªããæ¥ãä»äžãã§ã¯ãªãæ§æãããæçµäœåãå埩ããã¢ã¬ãã¥ãŒããæéãããã 6 ã¶æãããŸããåŒãç¶ããããã¶ã€ã³ååã«ã€ããŠã¯ã
AAIC 2026 ã§åã€ãã¹ã¿ãŒã®ãã¶ã€ã³æ¹æ³ ãåç
§ããŠãã ããã
8. AI é§åã®èŠèŠçæïŒAAIC 2026 SciFig ã¯ãŒã¯ãããŒ
ããªãã¯ãã£ãªã¢åæã®ååãæã£ãŠããªã 2 ã€ã®è³ç£ãæ¢ã«æã«ããŠããŸãïŒæ¡æãããæé² PDFïŒ3 æäžæ¬ã®å€å®ã¡ãŒã«ã«æ·»ä»ïŒãšãèªèº«ã®ç ç©¶ã®ãã€ãªããžãŒãžã®æç¢ºãªçè§£ãäž¡æ¹ã掻çšããŸãããã
Path 1 â æ¡æãããæé² PDF ãã¢ããããŒãããã PDF ã SciFig ã®
PDF-to-Figure ããŒã« ã«ããããããŸããBackgroundãMethodsãResults ãè§£æãã1 ã¯ãªãã¯ã§ã¹ã¿ãŒã¿ãŒã¡ã«ããºã å³ãçæããŸããå€ãã®èšåºæé²ã§ã¯ã詊éšã¹ããŒããšçŸæ£ã¡ã«ããºã å³ã®åçš¿ãæ°ç§ã§åŸãããŸã â ãŒãããã§ã¯ãªããç ç©¶ã®ãã€ãªããžãŒãæ¢ã«çè§£ãã 70% 宿ã®ãã©ãããã磚ãå§ããããšã«ãªããŸãã
Path 2 â æ§é åããã³ãããã³ããŒããã ãµããŒãå³ïŒAPP ããã»ãã·ã³ã°ãTREM2 ã·ã°ãã«äŒéãæµ·éŠ¬è§£åïŒã«ã€ããŠã¯ã
Text-to-Figure ã®ã»ãã现ããå¶åŸ¡ãå¯èœã§ããã¢ããã€ãæç
çã®ã¹ã¿ãŒã¿ãŒããã³ããïŒ
Cross-section of Alzheimer's disease brain tissue showing dense-core
amyloid-beta plaque (Aβ42 fibrils) in extracellular matrix, surrounded by
dystrophic neurites, activated microglia engulfing plaque periphery,
reactive astrocytes nearby. Healthy neurons in background for contrast.
Publication-style illustration with callout labels for plaque core,
corona, and microglial processes.
Path 3 â ã¿ãã¬ããã§ã¹ã±ããããåçãã¢ããããŒãããã çŽã®äžã§äž»åœ¹å³ã®ãã©ãããæãããªãããããæ®åœ±ã㊠Sketch-to-Figure ã«æå
¥ããŸããã¢ãã«ã¯ããªãã®ããããžãŒ â å容äœäœçœ®ãç¢å°æ¹åãã³ã³ããŒãã¡ã³ãå¢ç â ãä¿ã¡ã€ã€ãç§åŠç倿ãç¶æãããŸãŸåºçã¹ã¿ã€ã«ã®ããŒãžã§ã³ãçæããŸãã
SciFig Text-to-Figure ã€ã³ã¿ãŒãã§ãŒã¹ïŒå·ŠåŽã®ã¢ããã€ãæããã³ããå
¥åãå³åŽãã£ã³ãã¹ã«æç»ããã Alzheimer ç
ç
çå³ãPPTX/SVG/8K 圢åŒã®æžãåºãããŒã«ããŒïŒå³ã¯ SciFig ã§çæïŒ
ãããã®ãã¹ããã§ããããã³ãããæŽç·Žãããã¯ã¿ãŒèŠçŽ ãç·šéããç·šéå¯èœãª PPTX ãŸãã¯ã¬ã€ã€ãŒåããã SVG ã«æžãåºããA0 å°å·åãã« 8K è§£å床ã§çæã§ããŸãã5 æã®ã³ã¢èªç¥çå³ â ã¹ããŒããã¢ããã€ããAPPãTREM2 / ãã¯ãã°ãªã¢ãçµæããžã¥ã¢ã« â ã®æ§ç¯ã¯ã25ã40 æéã®ãã¶ã€ã³äœæ¥ãã ããã 4ã6 æéã®ããã³ããã£ã³ã°ãšæŽç·Ž ã«å§çž®ãããŸãã4 é±éãŠã£ã³ããŠã®äžã§åã Developing Topics èè
ã«ãšã£ãŠãããã¯å°å·ç· åã«éã«åããåŠããåããå·®ã§ãã
PDFããå³è¡šæœåºãå®è·µã§èŠã
ç ç©¶PDFãã¢ããããŒã â SciFigãå³è¡šãæœåºããç·šéå¯èœãªSVGãšããŠåçæã
ããŒã«ãæ¢çŽ¢
æ°èŠ SciFig ã¢ã«ãŠã³ãã¯
150 ã¹ã¿ãŒã¿ãŒã¯ã¬ãžãã ã«å ã
æ¯æ¥ 50 ãªãã£ã«ã¯ã¬ãžãã ã§å§ãŸããŸããåºçã¹ã¿ã€ã«ã®å³ 5 æã¯éåžž
30ã60 ã¯ã¬ãžãã ãæ¶è²»ããŸããéåžžæ¡æã® Poster Presentation èè
ã®å€ãã¯ã远å 賌å
¥ãªãã§æåã®æºåé±éå
ã«èŠèŠã»ããå
šäœã宿ãããŸã â å€ãã®å埩ã FRS ã»ãã·ã§ã³ã®å³èª¿æŽãèŠèŸŒãå Žåã¯
æéããŒãž ã確èªããŠãã ãããåçš¿ã§é¿ããã¹ããã¹ã«ã€ããŠã¯ã
ç ç©¶è
ãç§åŠçå³è§£ã§ç¯ããã¡ãª 5 ã€ã®äžè¬çãã¹ ãåç
§ããŠãã ããã
PDFããå³è¡šãæœåº
ç§åŠè«æã®å³è¡šãç·šéå¯èœãªåºçå質ã®ã€ã©ã¹ãã«å€æã
ç¡æã§è©Šã
9. AAIC 2026 Congress åãã§ãã¯ãªã¹ã
å°å·ãããã¹ã¿ãŒããã³ãã³ã«çºéããåã«ç¢ºèªãã¹ã 11 é
ç®ã§ãã
Tip
æ®ãããæºåãŠã£ã³ããŠã§æãã¬ãã¬ããžã®é«ã決å®ã¯ ã©ã®å³ãããŒããŒã«ããã ã§ããæ¥å Žè
ã 24 æéåŸã«ãèŠããŠããŠã»ããå³ãéžã³ â éåžžã¯ã¡ã«ããºã å³ããäž»èŠãšã³ããã€ã³ããéãã詊éšã¹ããŒã â ãã®å³ãäžå¿ã«ãã¹ã¿ãŒå
šäœãèšèšããŸãããã
FAQ
AAIC 2026 ãã¹ã¿ãŒã®ãµã€ãºã¯ã©ããããã§ããïŒ
AAIC ã® Podium Presentation ãš Featured Research Session ã®éãã¯äœã§ããïŒ
AAIC 2026 Developing Topics æé²ã®ç· åã¯ãã€ã§ããïŒ
Beyond the Data ãšã¯äœã§ããïŒèŠèŠèžè¡ã¯ã©ãæçš¿ããŸããïŒ
AAIC ãã¹ã¿ãŒã¯ãã³ãã³çŸå°ã§å°å·ããå¿
èŠããããŸããïŒ
å
責äºé
ïŒæ¬èšäºã¯äŒè°ãã¹ã¿ãŒããã³åºçç©åãã®ç§åŠçå³è¡šèšèšã®æè²çå
容ã§ãããå»åŠçå©èšã§ã¯ãããŸãã ãèšåºç倿ã«çšããã¹ãã§ã¯ãããŸãããæ¬èšäºã§èšåããçŸæ£ã¡ã«ããºã ãè¬å€é©å¿ãæ²»çãããã³ã«ã¯äžèšåŒçšæç®ããèŠçŽãããã®ã§ããèšåºå®åã«ãããŠã¯ãåèæç®ãå
¬åŒèšºçã¬ã€ãã©ã€ã³ãããã³æè³æ Œã®èšåºå»ã«çžè«ããŠãã ãããSciFig ã¯ç§åŠçã€ã©ã¹ãã¬ãŒã·ã§ã³ããŒã«ã§ããã蚺æãæ²»çããŸãã¯æ£è
管çã«é¢ããå©èšã¯è¡ããŸããã